Clinical Trial Update: Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial of hormone ablation therapy with doxorubicin and zoledronic acid, with or without Strontium-89, in androgen-dependent prostate cancer with bone me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• Strontium-89 chloride (Strontium-89 chloride)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Cancer, Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-10